30th March 2022 | Pharma Updates
PharmaState Updates – Latest Pharma Happenings Aleor Dermaceuticals is acquired by Alembic Pharma Alembic Pharmaceuticals has acquired 40% of Aleor Dermaceuticals Ltd from its joint-venture…
Davos Manifesto and FoE’s to Raise Profitability Of Your Firm
Have you heard of the Davos Manifesto? Every year the World Economic Forum (WEF) is held at Davos. The purpose of its annual meeting is to…
29th March 2022 | Pharma Updates
PharmaState Updates – Latest Pharma Happenings India adds 1,270 additional COVID-19 cases, bringing the active cases decline to 15,859 cases COVID-19 immunisation coverage in India…
H2H Brand Management
What is H2H Brand Management? It is co-creation of a brand along with the consumers (for pharma, the patients, and doctors) is one of the essential…
28th March 2022 | Pharma Updates
PharmaState Updates – Latest Pharma Happenings Tata Trusts’ IHF invests in a firm that developed a low-cost test to detect drug-resistant tuberculosis HealSeq will be…
H2H Marketing – Humans Have Problems and Marketers Have To Find Solutions
Hello everyone. How does Philip Kotler, the grand guru of marketing, define marketing? Today, we marketers generally have a tendency of speaking either B2B,…
25th March 2022 | Pharma Updates
PharmaState Updates – Latest Pharma Happenings Tata Trusts’ IHF invests in a firm that developed a low-cost test to detect drug-resistant tuberculosis HealSeq will be…
24th March 2022 | Pharma Updates
PharmaState Updates – Latest Pharma Happenings DCGI approved the Covid-19 vaccine Covovax for phase 3 clinical trial Drugs Controller General of India cleared the phase…
H2H Marketing Doesn’t Feel Like Marketing
Changes in pharma marketing will be profound in the foreseeable future. Not just with the advent of technology, but also with the adoption of the…
22nd March 2022 | Pharma Updates
PharmaState Updates – Latest Pharma Happenings Hetero received CDSCO approval to commercialise Sputnik Light vaccine Hetero to gain Manufacturing and Marketing approval for a COVID-19…
You must be logged in to post a comment.